Osteopontin of either host or tumor origin critically affects malignant pleural effusion formation

I. Psallidas, G. Stathopoulos, C. Moschos, A. Kollintza, K. Karabela, D. Simoes, S. Papiris, I. Kalomenidis (Haidari, Athens, Greece)

Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Session: Basic mechanisms in malignant pleural disease biology
Session type: Oral Presentation
Number: 3852
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Psallidas, G. Stathopoulos, C. Moschos, A. Kollintza, K. Karabela, D. Simoes, S. Papiris, I. Kalomenidis (Haidari, Athens, Greece). Osteopontin of either host or tumor origin critically affects malignant pleural effusion formation. Eur Respir J 2010; 36: Suppl. 54, 3852

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Osteopontin is important for malignant pleural effusion formation
Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease?
Year: 2009

Host-derived osteopontin is important for malignant pleural effusion formation
Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Year: 2008


Malignant pleural effusion cells show aberrant glucose metabolism gene expression
Source: Eur Respir J 2011; 37: 1453-1465
Year: 2011



The value of IL6 in differentiation between malignant and non malignant pleural effusion
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


All-trans-retinoic acid inhibits tumor growth of malignant pleural mesothelioma in mice
Source: Annual Congress 2010 - Basic mechanisms in malignant pleural disease biology
Year: 2010



Talc mediates angiostasis in malignant pleural effusions via endostatin induction
Source: Eur Respir J 2007; 29: 761-769
Year: 2007



Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma
Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions
Year: 2012

C-reactive protein in differentiation between tuberculous and malignant pleural effusions
Source: Annual Congress 2011 - Clinical challenges in tuberculosis
Year: 2011

Non-classical monocytes potentiates the pathogenesis of malignant pleural effusion via the production of IL-1ß
Source: International Congress 2019 – Biology of lung cancer
Year: 2019

Diagnostic usefulness of C reactive protein levels in pleural effusions of malignant and non malignant origin
Source: Eur Respir J 2007; 30: Suppl. 51, 431s
Year: 2007

Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion?
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017


Early pleural fluid control is warranted to prevent reaccumulation of malignant pleural effusion in oncogene-driven lung cancer
Source: International Congress 2019 – Brain Metastasis and Malignant pleural effusion: improving our understanding
Year: 2019




Prognostic role of inflammatory cells in blood, pleural fluid and tumour samples, in patients with malignant pleural mesothelioma (MPM)
Source: International Congress 2017 – Mesothelioma and malignant pleural disease
Year: 2017


Interleukin-8 and other mediators are related to tumour burden in malignant pleural effusions (MPE)
Source: Eur Respir J 2007; 30: Suppl. 51, 103s
Year: 2007

Mast cells recruitment to malignant pleural effusions
Source: Annual Congress 2010 - Current issues in malignant pleural diseases
Year: 2010


A novel clinical role for angiopoietin-1 in malignant pleural mesothelioma
Source: Eur Respir J 2010; 36: 1099-1105
Year: 2010



Is it important to determine pleural fluid amylase in patients with malignant pleural effusions?
Source: Eur Respir J 2007; 30: Suppl. 51, 565s
Year: 2007

Expression of human mammaglobin gene in pleural effusion of patients affected by malignant pleural mesothelioma (MM)
Source: Eur Respir J 2004; 24: Suppl. 48, 81s
Year: 2004

Diagnostic value of detection of promoter hypermethylation of tumor suppressor genes in pleural fluid for diagnosis of malignant pleural effusion
Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach
Year: 2010


Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions
Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement?
Year: 2010